Managing the risks of commencing insulin therapy for patients with type 2 Diabetes

Listed under:

Date Reviewed:


Commencing insulin therapy in patients with diabetes introduces a number of patient safety risks, including hypoglycaemia. Healthcare professionals commonly lack the expertise and time to educate each patient about titrating their changing dose requirements.

This discussion paper by Laila King, a diabetes specialist nurse educator, looks and current best practice and guidelines around commencing insulin therapy. It will be useful for clinicians introducing patients to a new insulin regime.

Read more on Diabetes

Post comment

* indicates required field

Your email address will not be published on the site and will only be used if we need to contact you about your comment.

View our comments policy.